Texas Attorney General Files Lawsuit Against Tylenol Makers Concerning Autism Assertions
The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, asserting the corporations withheld alleged dangers that the pain reliever created to pediatric neurological development.
This legal action arrives a month after Former President Trump publicized an unverified association between consuming Tylenol - alternatively called paracetamol - while pregnant and autism spectrum disorder in young ones.
The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic recommended for women during pregnancy, and the current manufacturer, which now manufacturers it.
In a statement, he stated they "betrayed America by profiting off of discomfort and pushing pills without regard for the risks."
Kenvue asserts there is lacking scientific proof tying acetaminophen to autism.
"These corporations lied for decades, intentionally threatening millions to line their pockets," Paxton, from the Republican party, declared.
The manufacturer said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the health of women and children in America."
On its official site, Kenvue also stated it had "continuously evaluated the applicable studies and there is insufficient valid information that indicates a established connection between consuming paracetamol and autism spectrum disorder."
Associations representing physicians and medical practitioners concur.
The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in acetaminophen - is one of the few options for pregnant women to address discomfort and elevated temperature, which can present major wellness concerns if ignored.
"In over twenty years of investigation on the utilization of acetaminophen in pregnancy, not a single reputable study has definitively established that the consumption of paracetamol in any period of gestation leads to brain development issues in young ones," the organization commented.
This legal action references recent announcements from the previous government in arguing the drug is potentially dangerous.
Recently, Trump caused concern from public health officials when he instructed women during pregnancy to "struggle intensely" not to use acetaminophen when sick.
The FDA then released a statement that physicians should think about restricting the consumption of acetaminophen, while also declaring that "a causal relationship" between the drug and autism spectrum disorder in minors has not been established.
The Health Department head Robert F Kennedy Jr, who manages the FDA, had promised in spring to undertake "comprehensive study program" that would identify the source of autism in a short period.
But specialists advised that discovering a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a complex mix of inherited and environmental factors - would be difficult.
Autism is a form of enduring cognitive variation and impairment that influences how people experience and engage with the surroundings, and is identified using physician assessments.
In his legal document, Paxton - a Trump ally who is running for the Senate - alleges Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.
The lawsuit aims to force the corporations "remove any promotional materials" that asserts acetaminophen is safe for women during pregnancy.
The court case mirrors the grievances of a collection of parents of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of acetaminophen in 2022.
Judicial authorities threw out the legal action, stating studies from the family's specialists was not conclusive.